Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma
1994

Selective Venous Sampling for Medullary Thyroid Carcinoma

Sample size: 19 publication Evidence: high

Author Information

Author(s): N. Abdelmoumenel, M. Schlumberger, P. Gardet, A. Roche, J.P. Travagli, C. Francesel, C. Parmentier

Primary Institution: Institut Gustave-Roussy

Hypothesis

Is selective venous sampling catheterisation effective for localising persistent medullary thyroid carcinoma?

Conclusion

Selective venous catheterisation is the most sensitive method for localising residual medullary thyroid carcinoma and detecting distant metastases.

Supporting Evidence

  • Calcitonin gradients were found in the neck and/or mediastinum in 18 patients.
  • After surgery, serum calcitonin levels normalised in one patient and significantly decreased in five others.
  • Distant metastases emerged in all five patients with distant gradients.

Takeaway

Doctors used a special technique to find cancer that was still in the body after surgery, and it helped them see where the cancer might be hiding.

Methodology

Selective venous sampling catheterisation was performed on patients with high serum calcitonin levels to locate residual disease.

Limitations

The follow-up period was too short to fully understand the significance of extracervical gradients.

Participant Demographics

19 patients with medullary thyroid carcinoma, ages ranging from 6 to 52 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication